DOI: 10.1212/01.WNL.0000161871.83614.BB
2005;64;1704-1711
Neurology
Schmidt
C. Enzinger, F. Fazekas, P. M. Matthews, S. Ropele, H. Schmidt, S. Smith and R.
normal subjects
Risk factors for progression of brain atrophy in aging: Six-year follow-up of
This information is current as of August 18, 2008
http://www.neurology.org/cgi/content/full/64/10/1704
located on the World Wide Web at:
The online version of this article, along with updated information and services, is
All rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.
since 1951, it is now a weekly with 48 issues per year. Copyright © 2005 by AAN Enterprises, Inc.
® is the official journal of the American Academy of Neurology. Published continuously
Neurology
at Washington University on August 18, 2008
www.neurology.org
Downloaded from
Risk factors for progression of brain
atrophy in aging
Six-year follow-up of normal subjects
C. Enzinger, MD; F. Fazekas, MD; P.M. Matthews, MD, DPhil, FRCP; S. Ropele, PhD; H. Schmidt, MD;
S. Smith, DPhil; and R. Schmidt, MD
Abstract—Objectives: To determine the rate of brain atrophy in neurologically asymptomatic elderly and to investigate
the impact of baseline variables including conventional cerebrovascular risk factors, APOE 4, and white matter hyperin-
tensity (WMH) on its progression. Methods: We assessed the brain parenchymal fraction at baseline and subsequent
annual brain volume changes over 6 years for 201 participants (F/M 96/105; 59.8 5.9 years) in the Austrian Stroke
Prevention Study from 1.5-T MRI scans using SIENA (structural image evaluation using normalization of atrophy)/
SIENAX (an adaptation of SIENA for cross-sectional measurement)(www.fmrib.ox.ac.uk/fsl). Hypertension, cardiac dis-
ease, diabetes mellitus, smoking, and regular alcohol intake were present in 64 (31.8%), 60 (29.9%), 5 (2.5%), 70 (39.3%),
and 40 (20.7%) subjects, respectively. Plasma levels of fasting glucose (93.7 18.6 mg/dL), glycated hemoglobin A (HbA1c;
5.6 0.7%), total cholesterol (228.3 40.3 mg/dL)